WESTBROOK, Maine, Feb. 20, 2023 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced a first-of-its-kind empirical study aimed at addressing veterinary practice capacity constraints. In the publication Finding the Time: Empowering Veterinary Teams to Get the Most Out of Every Day, IDEXX introduces the veterinary Practice Productivity Index™, a data-driven framework and collection of guides for transforming practice productivity across the dimensions of workflow, technology, and culture. Depending on where a practice sits on the Practice Productivity Index, the study reveals opportunities to find up to 2,000 hours per year—the equivalent of adding one full-time veterinarian.* The findings are based on 786 survey participants, in-depth clinical observations, financial evaluations, and extensive practice-level data.
"Veterinary professionals operate in an entirely new landscape compared to a few years ago," said Jay Mazelsky, IDEXX President and Chief Executive Officer. "Veterinary practices have asked us for strategies and solutions to address the challenges they're facing. A key insight from the study is that small steps can help them find more hours in the day, and when improvements are implemented strategically, they can have a significant impact."
Finding the Time: Empowering Veterinary Teams to Get the Most Out of Every Day sheds light on staffing challenges throughout the veterinary industry while providing strategies for creating additional capacity and ultimately supporting a happier, healthier veterinary team.
"Having great technology has been a game-changer for our business," said Dr. Christine McCully of Downtown Pet Hospital. "Our practice management software is connected to patient records, diagnostics, and communications tools, so no one on my team wastes time figuring out where information is. Sometimes it's just a minute we save—but those minutes add up when it means the difference between seeing an extra patient or making sure we have time to eat lunch."
IDEXX will be hosting multiple sessions discussing the study at the WVC Annual Conference, the world's largest veterinary continuing education conference, taking place in Las Vegas February 19–22. Those not attending the WVC Annual Conference may download a copy of the publication, including productivity guides, at www.idexx.com/FindingTime.
About IDEXX
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries. For more information about IDEXX, visit www.idexx.com. For media inquiries, please get in touch at This email address is being protected from spambots. You need JavaScript enabled to view it..
*Amount of time saved depends on practice size and placement on the Practice Productivity Index.
Last Trade: | US$432.36 |
Daily Change: | 5.10 1.19 |
Daily Volume: | 573,187 |
Market Cap: | US$35.400B |
October 31, 2024 August 21, 2024 August 06, 2024 June 04, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load